ref,trial_char,outcome,tidy_trial_char_tabular,tidy_trial_char_heatmap,trial_char_group,tidy_trial_char_old
49,Treatment frequency,associated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
49,Treatment frequency,associated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
49,Location,associated,Trial location(s),Trial design | Location(s),Trial design,Trial design
49,Publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
49,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
49,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
49,intervention with placebo pill,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
49,deviation bias,unassociated,Risk of bias,Quality/Risk of bias,Quality/Risk of bias,Risk of bias
49,Publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
49,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
49,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
49,intervention with placebo pill,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
49,deviation bias,unassociated,Risk of bias,Quality/Risk of bias,Quality/Risk of bias,Risk of bias
49,Publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
49,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
49,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
49,intervention with placebo pill,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
49,deviation bias,unassociated,Risk of bias,Quality/Risk of bias,Quality/Risk of bias,Risk of bias
55,Multimedia elements score,associated,Participant engagement,Outcome | Engagement/Response,Outcome measures,Outcome measures
55,Multimedia elements score,associated,Participant engagement,Outcome | Engagement/Response,Outcome measures,Outcome measures
55,Overall engagement score,associated,Participant engagement,Outcome | Engagement/Response,Outcome measures,Outcome measures
55,Publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
55,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
55,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
55,intervention with placebo pill,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
55,deviation bias,unassociated,Risk of bias,Quality/Risk of bias,Quality/Risk of bias,Risk of bias
55,Publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
55,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
55,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
55,intervention with placebo pill,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
55,deviation bias,unassociated,Risk of bias,Quality/Risk of bias,Quality/Risk of bias,Risk of bias
55,Publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
55,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
55,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
55,intervention with placebo pill,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
55,deviation bias,unassociated,Risk of bias,Quality/Risk of bias,Quality/Risk of bias,Risk of bias
70,Recruitment method,associated,Recruitment strategies,Recruitment-related,Recruitment-related,Recruitment-related
70,Follow-up duration,associated,Follow-up duration,Follow-up related,Follow-up related,Follow-up related
70,Financial incentives for smoking cessation,associated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
70,Retention strategies,unassociated,Use of retention strategies,Trial design | Retention strategies,Trial design,Trial design
70,non-smoking related financial inentives,unassociated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
70,biomarker assessments,unassociated,Biomarker assessments,Outcome | Biomarkers,Outcome measures,Outcome measures
70,primary endpoint,unassociated,Primary endpoint,Outcome | Primary endpoint,Outcome measures,Outcome measures
70,intervention format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
70,treatment frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
70,pharmacological support,unassociated,Pharmacological support,Intervention components,Intervention-related,Intervention components
70,setting,unassociated,Trial design,Trial design,Trial design,Trial design
70,adjuvant interventions,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
70,number of behaviour change techniques (BCTs) used,unassociated,Number of components,Intervention components,Intervention-related,Intervention components
70,Retention strategies,unassociated,Use of retention strategies,Trial design | Retention strategies,Trial design,Trial design
70,non-smoking related financial inentives,unassociated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
70,biomarker assessments,unassociated,Biomarker assessments,Outcome | Biomarkers,Outcome measures,Outcome measures
70,primary endpoint,unassociated,Primary endpoint,Outcome | Primary endpoint,Outcome measures,Outcome measures
70,intervention format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
70,treatment frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
70,pharmacological support,unassociated,Pharmacological support,Intervention components,Intervention-related,Intervention components
70,setting,unassociated,Trial design,Trial design,Trial design,Trial design
70,adjuvant interventions,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
70,number of behaviour change techniques (BCTs) used,unassociated,Number of components,Intervention components,Intervention-related,Intervention components
70,Retention strategies,unassociated,Use of retention strategies,Trial design | Retention strategies,Trial design,Trial design
70,non-smoking related financial inentives,unassociated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
70,biomarker assessments,unassociated,Biomarker assessments,Outcome | Biomarkers,Outcome measures,Outcome measures
70,primary endpoint,unassociated,Primary endpoint,Outcome | Primary endpoint,Outcome measures,Outcome measures
70,intervention format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
70,treatment frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
70,pharmacological support,unassociated,Pharmacological support,Intervention components,Intervention-related,Intervention components
70,setting,unassociated,Trial design,Trial design,Trial design,Trial design
70,adjuvant interventions,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
70,number of behaviour change techniques (BCTs) used,unassociated,Number of components,Intervention components,Intervention-related,Intervention components
94,Condition type,associated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
94,Sample size,associated,Sample size,Trial design | Sample size,Trial design,Trial design
95,Intervention components,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
95,intervention type,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
95,session frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
95,session intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
95,session volume,unassociated,Setting,Trial design | Setting,Trial design,Trial design
95,delivery format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
95,setting,unassociated,Trial design,Trial design,Trial design,Trial design
95,intervention duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
95,supervision used,unassociated,Intervention supervision,Intervention supervision,Intervention-related,Intervention supervision
95,intervention tailoring,unassociated,Preference/Tailoring,Preference/Tailoring,Preference/Tailoring,Preference/Tailoring
95,intervention adherence,unassociated,Treatment adherence,Outcome | Treatment adherence,Outcome measures,Outcome measures
99,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
102,Study design,associated,Trial design,Trial design,Trial design,Trial design
102,Delivery format,associated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
102,Delivery format,associated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
102,Follow-up duration,associated,Follow-up duration,Follow-up related,Follow-up related,Follow-up related
102,Intervention duration,associated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
102,Number of arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
102,enrollment setting,unassociated,Enrolment setting,Enrolment-related,Enrolment-related,Enrolment-related
102,enrollment method,unassociated,Enrolment method,Enrolment-related,Enrolment-related,Enrolment-related
102,Number of arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
102,enrollment setting,unassociated,Enrolment setting,Enrolment-related,Enrolment-related,Enrolment-related
102,enrollment method,unassociated,Enrolment method,Enrolment-related,Enrolment-related,Enrolment-related
102,Number of arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
102,enrollment setting,unassociated,Enrolment setting,Enrolment-related,Enrolment-related,Enrolment-related
102,enrollment method,unassociated,Enrolment method,Enrolment-related,Enrolment-related,Enrolment-related
102,Number of arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
102,enrollment setting,unassociated,Enrolment setting,Enrolment-related,Enrolment-related,Enrolment-related
102,enrollment method,unassociated,Enrolment method,Enrolment-related,Enrolment-related,Enrolment-related
102,Number of arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
102,enrollment setting,unassociated,Enrolment setting,Enrolment-related,Enrolment-related,Enrolment-related
102,enrollment method,unassociated,Enrolment method,Enrolment-related,Enrolment-related,Enrolment-related
107,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,Setting,associated,Setting,Trial design | Setting,Trial design,Trial design
111,Intervention frequency,associated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
111,Intervention duration,associated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
111,Supervision format,associated,Intervention supervision,Intervention supervision,Intervention-related,Intervention supervision
111,Qualifications of supervisor,associated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
111,Motivational strategies,associated,Use of motivational strategies,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
111,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention type,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
111,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention type,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
111,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention type,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
111,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention type,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
111,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention type,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
111,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention type,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
111,intervention intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
113,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
113,treatment duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
113,treatment intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
113,setting,unassociated,Trial design,Trial design,Trial design,Trial design
113,treatment orientation,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
113,trial randomisation,unassociated,Trial design,Trial design,Trial design,Trial design
113,use of phone coaching,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
113,presence of consultation team,unassociated,Presence of consultation team,Trial conduct,Trial conduct,Trial conduct
113,comorbidity targeted in addition to primary condition (BPD),unassociated,Comorbidities,Eligibility | Comorbidities,Eligibility criteria,Eligibility criteria
120,Treatment type,associated,Intervention type,Intervention type,Intervention-related,Intervention type
120,Treatment type,associated,Intervention type,Intervention type,Intervention-related,Intervention type
120,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
120,country or study,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
120,total sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
120,active treatment frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
120,session frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
120,use of telehealth,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
120,use of incentives,unassociated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
120,originator of active treatment being part of study team,unassociated,Involvement of treatment originator,Trial conduct,Trial conduct,Trial conduct
120,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
120,country or study,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
120,total sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
120,active treatment frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
120,session frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
120,use of telehealth,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
120,use of incentives,unassociated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
120,originator of active treatment being part of study team,unassociated,Involvement of treatment originator,Trial conduct,Trial conduct,Trial conduct
145,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
146,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
153,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
201,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
201,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
201,treatment dose,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
201,study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
211,Intervention elements,associated,Intervention components,Intervention components,Intervention-related,Intervention components
211,Intervention elements,associated,Intervention components,Intervention components,Intervention-related,Intervention components
211,Sample size,associated,Sample size,Trial design | Sample size,Trial design,Trial design
211,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
211,population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
211,eligibility criteria,unassociated,Eligibility criteria,Eligibility criteria,Eligibility criteria,Eligibility criteria
211,financial incentives,unassociated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
211,intervention duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
211,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
211,population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
211,eligibility criteria,unassociated,Eligibility criteria,Eligibility criteria,Eligibility criteria,Eligibility criteria
211,financial incentives,unassociated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
211,intervention duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
211,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
211,population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
211,eligibility criteria,unassociated,Eligibility criteria,Eligibility criteria,Eligibility criteria,Eligibility criteria
211,financial incentives,unassociated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
211,intervention duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
214,Treatment delivery format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
215,Treatment duration,associated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
215,Treatment protocols,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
217,Preference accommodation,associated,Preference/Tailoring,Preference/Tailoring,Preference/Tailoring,Preference/Tailoring
217,Preferred treatment,associated,Preference/Tailoring,Preference/Tailoring,Preference/Tailoring,Preference/Tailoring
221,Publication year,associated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
221,Placeo lead-in period,associated,Use of run-in period,Trial design | Use of run-in,Trial design,Trial design
221,Study location,associated,Trial location(s),Trial design | Location(s),Trial design,Trial design
221,Trial duration,associated,Trial duration,Trial design | Duration,Trial design,Trial design
221,Number of sites,associated,Number of sites,Trial design | Number of sites,Trial design,Trial design
221,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
221,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
221,number of active arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
221,response rate,unassociated,Response rate,Outcome | Engagement/Response,Outcome measures,Outcome measures
221,number of visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
221,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
221,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
221,number of active arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
221,response rate,unassociated,Response rate,Outcome | Engagement/Response,Outcome measures,Outcome measures
221,number of visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
221,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
221,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
221,number of active arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
221,response rate,unassociated,Response rate,Outcome | Engagement/Response,Outcome measures,Outcome measures
221,number of visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
221,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
221,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
221,number of active arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
221,response rate,unassociated,Response rate,Outcome | Engagement/Response,Outcome measures,Outcome measures
221,number of visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
221,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
221,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
221,number of active arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
221,response rate,unassociated,Response rate,Outcome | Engagement/Response,Outcome measures,Outcome measures
221,number of visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
222,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
222,Intervention format,associated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
222,Financial incentives,associated,Using incentives,Motivational/Incentive strategies,Motivational/Incentive strategies,Motivational/Incentive strategies
222,Reminders for engagement,associated,Use of reminders,Trial design | Retention strategies,Trial design,Trial design
222,Enrollment method,associated,Enrolment method,Enrolment-related,Enrolment-related,Enrolment-related
222,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
222,interventions with mindfulness elements,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
222,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
222,interventions with mindfulness elements,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
222,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
222,interventions with mindfulness elements,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
222,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
222,interventions with mindfulness elements,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
222,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
222,interventions with mindfulness elements,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
225,Study duration,associated,Trial duration,Trial design | Duration,Trial design,Trial design
225,Intervention arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
225,Recruitment age limit,unassociated,Age limit,Eligibility criteria,Eligibility criteria,Eligibility criteria
225,region,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
225,study size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
225,Recruitment age limit,unassociated,Age limit,Eligibility criteria,Eligibility criteria,Eligibility criteria
225,region,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
225,study size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
227,Therapist attending consultant team meetings,associated,Clinician-Consultant meetings,Trial conduct,Trial conduct,Trial conduct
227,Availability of telephone crisis coaching,associated,Clinician telephone crisis coaching,Trial conduct,Intervention-related,Trial conduct
227,Targeted disorder,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
227,dropout definition,unassociated,Dropout definition,Dropout definition,Quality/Risk of bias,Dropout definition
227,delivery format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
227,therapist experience,unassociated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
227,therapist adherence,unassociated,Clinician protocol adherence,Trial conduct,Trial conduct,Trial conduct
227,treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
227,Targeted disorder,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
227,dropout definition,unassociated,Dropout definition,Dropout definition,Quality/Risk of bias,Dropout definition
227,delivery format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
227,therapist experience,unassociated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
227,therapist adherence,unassociated,Clinician protocol adherence,Trial conduct,Trial conduct,Trial conduct
227,treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
256,Publication year,associated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
256,Study duration,associated,Trial duration,Trial design | Duration,Trial design,Trial design
256,Number of sites,associated,Number of sites,Trial design | Number of sites,Trial design,Trial design
256,Placebo lead-in period,unassociated,Use of run-in period,Trial design | Use of run-in,Trial design,Trial design
256,number of arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
256,placebo randomisation rate,unassociated,Randomisation rate,Trial conduct,Trial conduct,Trial conduct
256,treatment regimen,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
256,active comparator class,unassociated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
256,setting,unassociated,Trial design,Trial design,Trial design,Trial design
256,number of countries,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
256,number of randomised subjects per site,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
256,Placebo lead-in period,unassociated,Use of run-in period,Trial design | Use of run-in,Trial design,Trial design
256,number of arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
256,placebo randomisation rate,unassociated,Randomisation rate,Trial conduct,Trial conduct,Trial conduct
256,treatment regimen,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
256,active comparator class,unassociated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
256,setting,unassociated,Trial design,Trial design,Trial design,Trial design
256,number of countries,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
256,number of randomised subjects per site,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
256,Placebo lead-in period,unassociated,Use of run-in period,Trial design | Use of run-in,Trial design,Trial design
256,number of arms,unassociated,Number of arms,Trial design | Number of arms,Trial design,Trial design
256,placebo randomisation rate,unassociated,Randomisation rate,Trial conduct,Trial conduct,Trial conduct
256,treatment regimen,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
256,active comparator class,unassociated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
256,setting,unassociated,Trial design,Trial design,Trial design,Trial design
256,number of countries,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
256,number of randomised subjects per site,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
269,Between-session intervention,associated,Intervention components,Intervention components,Intervention-related,Intervention components
269,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
269,targeted disorder,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
269,cognitive-behavioural interventions used in addition to primary treatment,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
269,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
282,Dropout definition,associated,Dropout definition,Dropout definition,Quality/Risk of bias,Dropout definition
282,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
282,Treatment format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
282,session duration,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
282,exclusion based on comorbidities,unassociated,Exclusions based on comorbidites,Eligibility | Comorbidities,Eligibility criteria,Eligibility criteria
282,Treatment format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
282,session duration,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
282,exclusion based on comorbidities,unassociated,Exclusions based on comorbidites,Eligibility | Comorbidities,Eligibility criteria,Eligibility criteria
288,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
288,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
288,Treatment intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
288,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
288,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
288,Treatment intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
288,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
288,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
301,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
326,Treatment modality,associated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
326,Treatment protocol,associated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
326,Number of sessions,associated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
326,Study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
326,dropout definition,unassociated,Dropout definition,Dropout definition,Quality/Risk of bias,Dropout definition
326,Study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
326,dropout definition,unassociated,Dropout definition,Dropout definition,Quality/Risk of bias,Dropout definition
326,quality assessment,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
326,Study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
326,dropout definition,unassociated,Dropout definition,Dropout definition,Quality/Risk of bias,Dropout definition
327,Therapist qualifications,associated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
327,Targeted condition,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
327,treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
327,treatment format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
327,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
327,session frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
327,methodological quality,unassociated,Methodological quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
358,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
378,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
378,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
396,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
399,Number of sessions,associated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
399,Study location,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
399,setting,unassociated,Trial design,Trial design,Trial design,Trial design
399,control intervention used,unassociated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
399,duration,unassociated,Trial duration,Trial design | Duration,Trial design,Trial design
399,number of evaluations,unassociated,Follow-up frequency/intensity,Follow-up related,Follow-up related,Follow-up related
399,study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
399,number of follow-up assessments,unassociated,Follow-up frequency/intensity,Follow-up related,Follow-up related,Follow-up related
413,Treatment type,associated,Intervention type,Intervention type,Intervention-related,Intervention type
413,Supervision format,associated,Intervention supervision,Intervention supervision,Intervention-related,Intervention supervision
413,Clinician qualifications,associated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
413,Setting,unassociated,Setting,Trial design | Setting,Trial design,Trial design
413,motivational elements,unassociated,Motivational/Incentive strategies,Motivational/Incentive strategies,Intervention-related,Motivational/Incentive strategies
413,treatment modality,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
413,intervention frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
413,intervention intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
413,Setting,unassociated,Setting,Trial design | Setting,Trial design,Trial design
413,motivational elements,unassociated,Motivational/Incentive strategies,Motivational/Incentive strategies,Intervention-related,Motivational/Incentive strategies
413,treatment modality,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
413,intervention frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
413,intervention intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
413,Setting,unassociated,Setting,Trial design | Setting,Trial design,Trial design
413,motivational elements,unassociated,Motivational/Incentive strategies,Motivational/Incentive strategies,Intervention-related,Motivational/Incentive strategies
413,treatment modality,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
413,intervention frequency,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
413,intervention intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
415,Study quality,associated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
415,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
417,Trial design,associated,Trial design,Trial design,Trial design,Trial design
440,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
448,Therapist qualifications,unassociated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
448,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
463,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
463,Setting,associated,Setting,Trial design | Setting,Trial design,Trial design
463,Intervention intensity,associated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
463,Motivational elements of intervention,associated,Motivational/Incentive strategies,Motivational/Incentive strategies,Intervention-related,Motivational/Incentive strategies
463,Supervision format,associated,Intervention supervision,Intervention supervision,Intervention-related,Intervention supervision
463,Supervisor qualification,associated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
463,Type of physical activity intervention,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
463,Type of physical activity intervention,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
463,Type of physical activity intervention,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
463,Type of physical activity intervention,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
463,Type of physical activity intervention,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
463,Type of physical activity intervention,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
465,Setting,associated,Setting,Trial design | Setting,Trial design,Trial design
465,Intervention type,associated,Intervention type,Intervention type,Intervention-related,Intervention type
465,Supervisor qualifications,associated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
465,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
465,Study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
465,publication type,unassociated,Publication type,Publication Type/Year,Publication details,Publication type
465,group exercise,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
465,supervision,unassociated,Intervention supervision,Intervention supervision,Intervention-related,Intervention supervision
465,Study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
465,publication type,unassociated,Publication type,Publication Type/Year,Publication details,Publication type
465,group exercise,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
465,supervision,unassociated,Intervention supervision,Intervention supervision,Intervention-related,Intervention supervision
465,Study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
465,publication type,unassociated,Publication type,Publication Type/Year,Publication details,Publication type
465,group exercise,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
465,supervision,unassociated,Intervention supervision,Intervention supervision,Intervention-related,Intervention supervision
465,Study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
465,publication type,unassociated,Publication type,Publication Type/Year,Publication details,Publication type
465,group exercise,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
465,supervision,unassociated,Intervention supervision,Intervention supervision,Intervention-related,Intervention supervision
490,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
490,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
490,region,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
490,setting,unassociated,Trial design,Trial design,Trial design,Trial design
490,target condition,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
490,therapist qualifications,unassociated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
490,study duration,unassociated,Trial duration,Trial design | Duration,Trial design,Trial design
490,number of intended sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
490,provider experience,unassociated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
498,Intervention type,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
498,number of modules,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
510,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
510,Human contact in delivery,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
510,treatment intensity,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
510,control type,unassociated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
510,follow-up intensity,unassociated,Follow-up frequency/intensity,Follow-up related,Follow-up related,Follow-up related
510,follow-up duration,unassociated,Follow-up duration,Follow-up related,Follow-up related,Follow-up related
535,Study duration,unassociated,Trial duration,Trial design | Duration,Trial design,Trial design
535,treatment formulation,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
535,treatment schedule,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
535,number of centres,unassociated,Number of sites,Trial design | Number of sites,Trial design,Trial design
535,number of sensitisations,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
535,country of study,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
538,Reporting year,associated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
538,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
551,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
551,Active control type,unassociated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
551,active treatment type,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
567,Study type,associated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
567,Treatment duration,associated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
567,Visit frequency,associated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
567,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
567,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
567,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
569,Treatment duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
569,dosing regimen,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
569,comorbidity as inclusion criterion,unassociated,Comorbidities,Eligibility | Comorbidities,Eligibility criteria,Eligibility criteria
569,lead-in period,unassociated,Use of run-in period,Trial design | Use of run-in,Trial design,Trial design
569,recruitment method,unassociated,Recruitment strategies,Recruitment-related,Recruitment-related,Recruitment-related
570,Model of care,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
586,Treatment modality,associated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
586,Number of sessions,associated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
586,Study size,associated,Sample size,Trial design | Sample size,Trial design,Trial design
586,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
590,Treatment delivery route,associated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
590,Trial duration,associated,Trial duration,Trial design | Duration,Trial design,Trial design
590,Trial design,associated,Trial design,Trial design,Trial design,Trial design
590,Medication restrictions,associated,Medication restrictions,Eligibility criteria,Eligibility criteria,Eligibility criteria
590,Prohibited escape medication,associated,Medication restrictions,Eligibility criteria,Eligibility criteria,Eligibility criteria
590,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
590,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
590,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
590,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
590,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
638,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
638,AE frequency,associated,Adverse event frequency,Outcome | Adverse event frequency,Outcome measures,Outcome measures
638,Use of nocebo,associated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
638,Number of participants,associated,Sample size,Trial design | Sample size,Trial design,Trial design
638,Number of placebo participants,associated,Sample size,Trial design | Sample size,Trial design,Trial design
638,Study year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,methodological quality,unassociated,Methodological quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
638,Study year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,methodological quality,unassociated,Methodological quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
638,Study year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,methodological quality,unassociated,Methodological quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
638,Study year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,methodological quality,unassociated,Methodological quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
638,Study year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
638,methodological quality,unassociated,Methodological quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
657,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
657,Trial duration,associated,Trial duration,Trial design | Duration,Trial design,Trial design
657,Methodological quality,unassociated,Methodological quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
657,Methodological quality,unassociated,Methodological quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
688,Publication year,associated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
688,Trial phase,associated,Trial phase,Trial design | Phase,Trial design,Trial design
688,Treatment frequency,associated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
688,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
688,population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
688,administration route,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
688,treatment duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
688,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
688,population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
688,administration route,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
688,treatment duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
688,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
688,population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
688,administration route,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
688,treatment duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
693,Study quality,associated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
693,Treatment duration,associated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
693,Treatment modality,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
693,Treatment modality,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
698,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
698,Publication year,associated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
698,Trial duration,unassociated,Trial duration,Trial design | Duration,Trial design,Trial design
698,dosing schedule,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
698,probability of receiving placebo,unassociated,Placebo randomisation,Trial conduct,Trial conduct,Trial conduct
698,Trial duration,unassociated,Trial duration,Trial design | Duration,Trial design,Trial design
698,dosing schedule,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
698,probability of receiving placebo,unassociated,Placebo randomisation,Trial conduct,Trial conduct,Trial conduct
713,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
713,Population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
713,recruitment method,unassociated,Recruitment strategies,Recruitment-related,Recruitment-related,Recruitment-related
713,psychological treatment type,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
713,treatment modality,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
713,methodology,unassociated,Methodological quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
713,study design,unassociated,Trial duration,Trial design | Duration,Trial design,Trial design
713,medication class,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
723,Treatment type,associated,Intervention type,Intervention type,Intervention-related,Intervention type
723,Lead-in period,associated,Use of run-in period,Trial design | Use of run-in,Trial design,Trial design
723,Comorbidity as inclusion criterion,associated,Comorbidities,Eligibility | Comorbidities,Eligibility criteria,Eligibility criteria
723,Number of visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
723,number of lifestyle visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
723,study location,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
723,Number of visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
723,number of lifestyle visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
723,study location,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
723,Number of visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
723,number of lifestyle visits,unassociated,Visit frequency,Trial design | Visit frequency,Trial design,Trial design
723,study location,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
725,Sample size,associated,Sample size,Trial design | Sample size,Trial design,Trial design
725,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
725,Number of arms,associated,Number of arms,Trial design | Number of arms,Trial design,Trial design
725,Treatment allocation,associated,Intervention type,Intervention type,Intervention-related,Intervention type
725,Duration,associated,Trial duration,Trial design | Duration,Trial design,Trial design
725,Cohort type,associated,Population studied,Trial design | Population,Trial design,Trial design
725,Study type,associated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
725,Location,associated,Trial location(s),Trial design | Location(s),Trial design,Trial design
725,Number of centres,associated,Number of sites,Trial design | Number of sites,Trial design,Trial design
731,Active drug class,associated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
731,Trial duration,associated,Trial duration,Trial design | Duration,Trial design,Trial design
731,Treatment modality,associated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
732,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
759,Drug class,associated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
778,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
788,Drug class,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
810,Drug class,associated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
810,Drug class,associated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
810,Drug class,associated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
810,Drug class,associated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
840,Study duration,associated,Trial duration,Trial design | Duration,Trial design,Trial design
840,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
840,study quality,unassociated,Trial quality,Quality/Risk of bias,Quality/Risk of bias,Quality/Risk of bias
854,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
869,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
869,Active drug class,associated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
875,Publication year,associated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
875,Active drug class,associated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
875,Trial duration,associated,Trial duration,Trial design | Duration,Trial design,Trial design
956,Run-in period,associated,Use of run-in period,Trial design | Use of run-in,Trial design,Trial design
996,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
996,intervention duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
996,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
1035,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
1198,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
1202,Active treatment type,associated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
1202,Study duration,unassociated,Trial duration,Trial design | Duration,Trial design,Trial design
1202,treatment discontinuation method,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
1202,dosing schedule,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
1202,run-in treatment duration,unassociated,Use of run-in period,Trial design | Use of run-in,Trial design,Trial design
1202,maintenance treatment duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
1202,location,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
1202,study year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
1202,targeted condition,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
1360,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
1519,Active treatment type,associated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
1519,Number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
1519,study duration,unassociated,Trial duration,Trial design | Duration,Trial design,Trial design
1519,setting,unassociated,Trial design,Trial design,Trial design,Trial design
1519,therapist qualifications,unassociated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
1519,baseline condition severity,unassociated,Index condition severity,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
1519,open-label,unassociated,Open label design,Trial design,Trial design,Trial design
1519,completers-only reporting,unassociated,Reporting method,Quality/Risk of bias,Quality/Risk of bias,Reporting method
1519,risk of bias,unassociated,Risk of bias,Quality/Risk of bias,Quality/Risk of bias,Risk of bias
1519,risk of allegiance,unassociated,Risk of bias,Quality/Risk of bias,Quality/Risk of bias,Risk of bias
1519,treatment-resistant focus,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
1519,treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
1643,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
1643,clinical diagnosis,unassociated,Comorbidities,Eligibility | Comorbidities,Eligibility criteria,Eligibility criteria
1643,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
1643,treatment duration,unassociated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
1643,current density,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
1643,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
1655,Intervention elements,associated,Intervention components,Intervention components,Intervention-related,Intervention components
1655,Intervention elements,associated,Intervention components,Intervention components,Intervention-related,Intervention components
1655,Intervention duration,associated,Intervention duration,Intervention duration,Intervention-related,Intervention duration
1655,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
1655,Study location,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
1655,Study location,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
1655,Study location,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
1655,Study location,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
2125,Having trained facilitators,associated,Clinician qualifications/training,Clinician qualifications/training,Trial conduct,Clinician qualifications/training
2125,Recruitment setting,associated,Recruitment setting,Recruitment-related,Recruitment-related,Recruitment-related
2125,Use of mindfulness based relapse prevention programmes,associated,Intervention components,Intervention components,Intervention-related,Intervention components
2125,Non-clinical population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
2125,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
2125,active treatment type,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
2125,control treatment type,unassociated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
2125,treatment format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
2125,treatment adaptation,unassociated,Population studied,Trial design | Population,Trial design,Trial design
2125,mindfulness-based relapse prevention programmes,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
2125,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
2125,country,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
2125,Non-clinical population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
2125,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
2125,active treatment type,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
2125,control treatment type,unassociated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
2125,treatment format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
2125,treatment adaptation,unassociated,Population studied,Trial design | Population,Trial design,Trial design
2125,mindfulness-based relapse prevention programmes,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
2125,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
2125,country,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
2125,Non-clinical population,unassociated,Population studied,Trial design | Population,Trial design,Trial design
2125,number of sessions,unassociated,Intervention frequency/intensity,Intervention frequency/intensity,Intervention-related,Intervention frequency/intensity
2125,active treatment type,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
2125,control treatment type,unassociated,Control/Comparator intervention type,Intervention type | Control/Comparator,Intervention-related,Intervention type
2125,treatment format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
2125,treatment adaptation,unassociated,Population studied,Trial design | Population,Trial design,Trial design
2125,mindfulness-based relapse prevention programmes,unassociated,Intervention components,Intervention components,Intervention-related,Intervention components
2125,publication year,unassociated,Publication/Reporting year,Publication Type/Year,Publication details,Publication/Reporting year
2125,country,unassociated,Trial location(s),Trial design | Location(s),Trial design,Trial design
2260,Trial design,associated,Trial design,Trial design,Trial design,Trial design
2260,Trial design,associated,Trial design,Trial design,Trial design,Trial design
2260,Drug-treatment group,associated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
2260,Placebo group,associated,Placebo treatment arm,Trial design | Placebo arm,Trial design,Trial design
2260,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
2260,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
2260,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
2260,Treatment arm,unassociated,Intervention type,Intervention type,Intervention-related,Intervention type
2307,Trauma focused therapy,associated,Intervention focus,Intervention components,Intervention-related,Intervention components
2307,Delivery format,unassociated,Intervention delivery/format,Intervention delivery/format,Intervention-related,Intervention delivery/format
2307,recruitment format,unassociated,Recruitment strategies,Recruitment-related,Recruitment-related,Recruitment-related
2342,Treatment arm,associated,Intervention type,Intervention type,Intervention-related,Intervention type
2520,Active treatment type,unassociated,Experimental intervention type,Intervention type | Experimental,Intervention-related,Intervention type
3001,Blinded groups,associated,Blinding,Trial design | Blinding,Trial design,Trial design
3048,Trial type,associated,Trial design,Trial design,Trial design,Trial design
3048,Follow-up strategy,associated,Follow-up strategy,Follow-up related,Follow-up related,Follow-up related
3048,Funding source,associated,Funding sources,Quality/Risk of bias,Quality/Risk of bias,Funding sources
3048,Location,associated,Trial location(s),Trial design | Location(s),Trial design,Trial design
3048,Follow-up duration,associated,Follow-up duration,Follow-up related,Follow-up related,Follow-up related
3048,Impact factor,unassociated,Impact factor,Publication Type/Year,Publication details,Publication/Reporting year
3048,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
3048,orthopaedic speciality,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
3048,Impact factor,unassociated,Impact factor,Publication Type/Year,Publication details,Publication/Reporting year
3048,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
3048,orthopaedic speciality,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
3048,Impact factor,unassociated,Impact factor,Publication Type/Year,Publication details,Publication/Reporting year
3048,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
3048,orthopaedic speciality,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
3048,Impact factor,unassociated,Impact factor,Publication Type/Year,Publication details,Publication/Reporting year
3048,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
3048,orthopaedic speciality,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
3048,Impact factor,unassociated,Impact factor,Publication Type/Year,Publication details,Publication/Reporting year
3048,sample size,unassociated,Sample size,Trial design | Sample size,Trial design,Trial design
3048,orthopaedic speciality,unassociated,Index condition type,Eligibility | Index condition,Eligibility criteria,Eligibility criteria
3123,Randomised patient preference treatment arm,associated,Preference/Tailoring,Preference/Tailoring,Preference/Tailoring,Preference/Tailoring
3123,Use of crossover,associated,Crossover design,Trial design | Use of crossover,Trial design,Trial design
